Feedback / Questions
fipaxalparant (AMG 670) - Amgen
Fipaxalparant: Data from P2 trial (NCT05032066) for IPF in H2 2024
(Amgen)
-
Feb 7, 2024 -
Q4 2023 Results
P2 data
•
Idiopathic Pulmonary Fibrosis
https://investors.amgen.com/static-files/e2a3ee45-b21d-4671-aad7-637bfdb8ec8b
Feb 7, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious